We are seeking a Corporate Development Manager with expertise in strategic planning and relationship building to further the goals of Neoteryx. This position offers an excellent opportunity for cross-functional work with internal stakeholders to assess, develop, and execute strategies that directly impact the success of Neoteryx and modernize healthcare.
To be successful in this role, you will:
We are looking for :
ABOUT NEOTERYX
Founded in 2014, Neoteryx is a medical device company shaping the future of healthcare. Our breakthrough blood collection technology – VAMS® – is used by pharmaceutical giants, organ transplant patients, researchers in economically disadvantaged regions, and others on the leading edge of science and medicine. When you join our fun, tight-knit team, you’ll discover what one drop of blood can do, and be part of microsampling innovations that will change the world.
Watch this video to learn more!
Department: Marketing
Reports to: Director of Marketing
Supervises: N/A
Status: Full Time
Type: Exempt
Schedule: 8am-5pm (PST)
Employee of: Neoteryx LLC
Location: Headquarters - Torrance, CA (USA)
Salary: Competitive, Depending on Experience
Benefits: Offered for Regular Full Time Employees
Travel: 25-30%
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.